INNV InnovAge Holding Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: INNV
  4. Earnings
?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 77
Relative Valuation: Rel. Valuation: 30
Relative Profitability: Rel. Profitability: 35

EPS in 2026 (TTM): -$0.08

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the current 12-month EPS is -$0.08. InnovAge Holding's earnings per share in 2025 was reported at -$0.22, marking a decrease from -$0.16 in 2024. In the quarterly report ending on Mar 31, 2026, INNV's earnings per share amounted to -$0.22.

INNV earnings history

Historical annual and quarterly earnings per share (EPS) data for InnovAge Holding
EPS (TTM)
-$0.08
EPS Growth YoY (Quarterly)
-175%
EPS (Quarterly)
-$0.22
EPS Growth (Quarterly)
-375%

InnovAge Holding had an yealy earnings per share of -$0.22, showing a decrease of 37.5% from -$0.16 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was -$0.22, showing a 175% decline compared to the same quarter last year. The trailing twelve months EPS for INNV is -$0.08 as of March 2026. InnovAge Holding's full-year EPS for 2024 was -$0.16, a 46.7% rise compared to the previous year.

INNV earnings chart

INNV EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-175%
EPS growth YoY
-37.5%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Over the past 12 months, InnovAge Holding has recorded an earnings per share growth rate of -175% (YoY, quarterly).

INNV Earnings Waterfall

Breakdown of revenue, profit and net income for InnovAge Holding

INNV Earnings vs Peers

What are the earnings of INNV compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
UTHR UNITED THERAPEUTICS Corp 18.69 14% 23.5% 20.9%
ANIP Ani Pharmaceuticals Inc 19.25 436.5% N/A N/A
MRK Merck & Co Inc 33.74 8% 8.4% 21.2%
COCP Cocrystal Pharma Inc N/A 54.7% N/A N/A
INNV InnovAge Holding Corp N/A -37.5% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.